$30,000 of PRIDE MOBILITY PRODUCTS CORP lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"DME industry relief, wheelchair upgrade legislation, Medicare coverage for power standing systems, wheelchair repair & service reform, tariffs on medical devices."
You can find more data on corporate lobbying on Quiver Quantitative.
CTS Insider Trading Activity
CTS insiders have traded $CTS stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.
Here’s a breakdown of recent trading of $CTS stock by insiders over the last 6 months:
- KIERAN M O'SULLIVAN (President & CEO) has made 0 purchases and 6 sales selling 80,000 shares for an estimated $4,435,835.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
CTS Hedge Fund Activity
We have seen 81 institutional investors add shares of CTS stock to their portfolio, and 112 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- GEODE CAPITAL MANAGEMENT, LLC removed 113,104 shares (-14.0%) from their portfolio in Q4 2024, for an estimated $5,963,973
- BLACKROCK, INC. removed 106,565 shares (-2.2%) from their portfolio in Q1 2025, for an estimated $4,427,775
- GOLDMAN SACHS GROUP INC added 87,749 shares (+82.2%) to their portfolio in Q4 2024, for an estimated $4,627,004
- WELLINGTON MANAGEMENT GROUP LLP removed 77,291 shares (-11.0%) from their portfolio in Q4 2024, for an estimated $4,075,554
- NORGES BANK removed 74,030 shares (-46.8%) from their portfolio in Q4 2024, for an estimated $3,903,601
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 73,435 shares (+3.4%) to their portfolio in Q4 2024, for an estimated $3,872,227
- VANGUARD GROUP INC removed 64,227 shares (-2.3%) from their portfolio in Q4 2024, for an estimated $3,386,689
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
